相关实验视频

Updated: Jul 5, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

固体瘤治疗的突破:CAR-NK免疫疗法

Wenkang Wang¹, Yang Liu², Zhen He³

¹Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. fccwangwk@zzu.edu.cn.

Cell death discovery

|January 20, 2024

概括

化学抗原受体自然杀手 (CAR-NK) 细胞疗法对固体瘤具有前景,比CAR-T具有优势. 本综述探讨了CAR-NK的结构,疗效因素以及它在治疗固体瘤方面的潜力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

与CAR-T疗法相比,CAR-NK疗法是一种新兴的免疫疗法,与CAR-T疗法相比,具有更高的安全性和有效性.
目前的研究主要集中在血性恶性瘤上,对固体瘤的探索有限.

研究的目的:

为了审查CAR-NK细胞的结构.
分析影响固体瘤中CAR-NK疗效的因素,包括缺氧,新陈代谢,NK细胞受体,细胞因子和外体.
评估CAR-NK治疗固体瘤的现状和潜力.

主要方法:

在固体瘤中对CAR-NK疗法的文献综述.
分析CAR-NK的结构和作用机制.
检查影响因素和临床研究现状.

主要成果:

卡尔-NK疗法显示出对固体瘤治疗的巨大潜力.
诸如瘤微环境 (低氧,新陈代谢) 和NK细胞成分 (受体,细胞因子,外体) 等因素对疗效产生重大影响.
为了CAR-NK应用,正在研究各种固体瘤.

结论:

CAR-NK疗法为固体瘤治疗提供了一个有前途的途径,在血液癌症的成功基础上发展.
解决与瘤微环境相关的挑战和优化CAR-NK设计对于临床翻译至关重要.
需要进一步的研究来克服局限性,并充分实现CAR-NK在固体瘤中的潜力.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...